ECSP088126A - HIV REVERSE TRANSCRIPT INHIBITORS - Google Patents

HIV REVERSE TRANSCRIPT INHIBITORS

Info

Publication number
ECSP088126A
ECSP088126A ECSP088126A ECSP088126A EC SP088126 A ECSP088126 A EC SP088126A EC SP088126 A ECSP088126 A EC SP088126A EC SP088126 A ECSP088126 A EC SP088126A
Authority
EC
Ecuador
Prior art keywords
hiv reverse
compounds
reverse transcript
inhibitors
prophylaxis
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Neville J Anthony
Dai-Shi Su
Robert M Tynebor
Sandeep A Saggar
John T Sisko
Thomas J Tucker
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ECSP088126A publication Critical patent/ECSP088126A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

RESUMEN DE LA INVENCIÓNCompuestos que tienen la estructura: son inhibidores de transcriptasa reversa de VIH, en los que A, X, Y, Z, R1 y R2 son como se definen en el presente documento. Los compuestos y sus sales farmacéuticamente aceptables son útiles en la inhibición de transcriptasa reversa de VIH, la profilaxis y tratamiento de la infección mediante VIH y en la profilaxis, retraso en la aparición, y tratamiento de SIDA. Los compuestos y sus sales se pueden emplear como ingredientes en composiciones farmacéuticas, opcionalmente en combinación con otros antivirales, inmunomoduladores, antibióticos o vacunas.SUMMARY OF THE INVENTION Compounds having the structure: they are HIV reverse transcriptase inhibitors, in which A, X, Y, Z, R1 and R2 are as defined herein. The compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of HIV infection and prophylaxis, delayed onset, and treatment of AIDS. The compounds and their salts can be used as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

ECSP088126 2005-07-22 2008-01-21 HIV REVERSE TRANSCRIPT INHIBITORS ECSP088126A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70179705P 2005-07-22 2005-07-22
US72791605P 2005-10-18 2005-10-18
US79070505P 2006-04-10 2006-04-10

Publications (1)

Publication Number Publication Date
ECSP088126A true ECSP088126A (en) 2008-02-20

Family

ID=40434918

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP088126 ECSP088126A (en) 2005-07-22 2008-01-21 HIV REVERSE TRANSCRIPT INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP088126A (en)

Similar Documents

Publication Publication Date Title
CR9694A (en) HIV REVERSE TRANSCRIPT INHIBITORS
ECSP099373A (en) NON-NUCLEOSIDAL INVERSE TRANSCRIPT INHIBITORS
ECSP066826A (en) HIV INTEGRAS INHIBITORS
CO7350655A2 (en) 5-Phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhibitors
ECSP12012201A (en) NON-NUCLEOSID INHIBITORS OF THE REVERSE TRANSCRIPT
CL2007002346A1 (en) NON-NUCLEOSIDIC COMPOUNDS DERIVED FROM FENOXI-FENIL SUBSTITUTED, INHIBITORS OF THE HIV REVERSE TRANSCRIPT; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT PREVENT AN HIV INFECTION OR TO TREAT AIDS OR CRS.
WO2008054605A3 (en) Non-nucleoside reverse transcriptase inhibitors
CO6382127A2 (en) HIV INTEGRAS INHIBITORS
BR112016022722A2 (en) hiv reverse transcriptase inhibitor prodrugs
WO2007002458A3 (en) Non-nucleoside reverse transcriptase inhibitors
DOP2006000176A (en) HIV REVERSE TRANSCRIPT INHIBITORS
WO2007021629A3 (en) Non-nucleoside reverse transcriptase inhibitors
WO2007002481A3 (en) Non-nucleoside reverse transcriptase inhibitors
WO2007002368A3 (en) Non-nucleoside reverse transcriptase inhibitors
ECSP088126A (en) HIV REVERSE TRANSCRIPT INHIBITORS
DOP2005000105A (en) HIV INTEGRAS INHIBITORS
CL2008003492A1 (en) Compounds derived from lysine sulfonamide; pharmaceutical composition; and its use for the inhibition of hiv protein, for the treatment or prophylaxis of hiv infection, or for the treatment, prophylaxis or delay of the onset of AIDS in a subject in need thereof.